A lipid-soluble antioxidant and cellular energy carrier reported to replenish age-depleted skin levels of coenzyme Q10, reduce oxidative stress, and support mitochondrial energy production in skin cells when applied topically or taken as a dietary supplement.
This ingredient page is still early. We're actively researching before it's ready to stand fully on its own — check back as more sections are verified.
The short answer
Four lines, each compressed from the section it links to. Every line carries the sources of the claim it compresses.
Everything the record says about suitability, consolidated. Pause-first comes first.
Before you start
Light-sensitive and heat-sensitive; best formulated with stabilizing carriers and stored away from direct light.
Best match
signs of aging
photoaged skin · dull or fatigued-looking skin
Routine
serum or moisturizer step
Pregnancy and breastfeeding
Not medical advice · ask your own clinician
Pregnancy.A 2011 dermatology review of skin-care product safety in pregnancy names hydroquinone (high systemic absorption) and tretinoin (evidence controversial) as the actives of concern, and states that most other topical skin-care products act locally and produce minimal systemic absorption; coenzyme Q10 is not named among the flagged concerns 6. This is general topical-product reasoning rather than an ingredient-specific safety trial. If you are pregnant, ask your doctor before use.
Breastfeeding.Topical application is applied locally with minimal expected systemic absorption; no ingredient-specific breastfeeding safety trial was located. As a general precaution common to topical actives, avoid applying directly to the breast or nipple area, since incidental transfer to a nursing infant has not been studied for this ingredient. If you are breastfeeding, ask your doctor before use.
Expected versus unacceptable reactions
Common, and it usually settles
reported well tolerated across its cited trials, with no irritation noted
The oral supplement trial cited above tests coenzyme Q10 combined with collagen peptides, not coenzyme Q10 alone; its own contribution is not isolated from collagen's.
Topical and oral delivery routes are reported separately in this record's own cited studies -- their benefits are not interchangeable or additive by assumption.
No admissible source in this cycle isolates coenzyme Q10's own topical contribution to elasticity or firmness specifically, distinct from wrinkle depth and antioxidant measures.
The evidence
One card per claim. Concentration, form, population and limitation sit with it, always visible.
Grade legend
Indicative
Limited
Moderate
Strong
Skin Q10 Replenishment and Antioxidant Effect
Indicative
Topical application of coenzyme Q10-containing formulas significantly increased Q10 levels in the epidermis, including in deeper layers, and provided antioxidant effects, reducing free radicals and increasing antioxidant capacity in stressed skin.1
Which form
Coenzyme Q10 (Ubiquinone)
Population and duration
Human volunteers and ex-vivo skin explants
Limitation
Does not report a specific wrinkle-reduction outcome in this study.
Reduced Wrinkle Depth with Topical Application
Indicative
Topical coenzyme Q10 penetrated into the viable epidermis, reduced markers of oxidation, and was associated with a reduction in wrinkle depth. It also reduced UVA-mediated oxidative stress markers in keratinocytes and suppressed UVA-induced collagenase expression in dermal fibroblasts.2
Tested concentration
0.3%
Which form
Coenzyme Q10 (Ubiquinone)
Population and duration
Human clinical evaluation and cell culture assays
Limitation
The packet's own claimed specific figures ('27% reduction', '6 months', '20 subjects') are not stated in this study's own published abstract and are not asserted here.
Mitochondrial Function Support in Skin Cells
Indicative
Aging skin shows age-dependent declines in mitochondrial function and shifts toward non-mitochondrial energy metabolism. Topical coenzyme Q10 was associated with improved mitochondrial function in skin. Separately, coenzyme Q10 accelerated regeneration of cellular ATP levels and preserved mitochondrial membrane potential in irradiated human skin fibroblasts.3,4
Which form
Coenzyme Q10 (Ubiquinone)
Population and duration
Human skin biopsies, volunteer panels, and human skin fibroblast cultures
Limitation
The packet's own claimed source for the fibroblast/ATP finding could not be found under its claimed title, journal, or year -- replaced with a genuine, closely related study by the same research group.
Oral Coenzyme Q10 and Collagen Supplement Improves Skin Parameters
Indicative
A randomized, double-blind, placebo-controlled trial of an oral water-soluble coenzyme Q10 and collagen supplement found improved dermis density, reduced periorbital wrinkle area, reduced total wrinkle score, and improved skin smoothness after 12 weeks, compared to placebo. Skin hydration, dermis thickness, transepidermal water loss, and viscoelasticity did not change significantly.5
Which form
Coenzyme Q10 (Ubiquinone)
Population and duration
34 healthy women aged 40-65 (17 treatment, 17 placebo) over 12 weeks
Limitation
This is an ORAL dietary supplement combined with collagen peptides, not a topical coenzyme Q10 application -- the packet's own claim framed this as topical, corrected here. Elasticity/viscoelasticity did not reach statistical significance, though the packet's own claim asserted it did -- corrected to remove that outcome.
○Open
A source cited for a coenzyme Q10 fibroblast/mitochondrial senescence claim could not be found under its claimed title, journal, or year -- no matching publication exists.
○Open
Several specific figures in the source packet's own claim descriptions (a '27% reduction in wrinkle depth', '6-month' duration, '20 subjects' for one topical trial) are not stated in that trial's own published abstract.
○Open
The packet's own claim for the water-soluble coenzyme Q10 plus collagen trial asserted a topical delivery route and a significant elasticity improvement; the real trial is an ORAL supplement, and its own abstract states elasticity/viscoelasticity changes were NOT statistically significant.
○Open
No resolved CIR/CosIng regulatory document id was found or confirmed this cycle for coenzyme Q10's cosmetic-ingredient status, despite the packet's own confident regulatory claims.
Topical Q10 treatment significantly increased Q10 levels in the epidermis (including deeper layers), augmented cellular energy metabolism in keratinocytes, and reduced free radicals while increasing antioxidant capacity in stressed skin.
Where it falls shortSponsored by the product manufacturer.
Topical CoQ10 penetrated the viable epidermis, reduced oxidation, and was associated with reduced wrinkle depth; suppressed UVA-mediated oxidative stress in keratinocytes and UVA-induced collagenase expression in dermal fibroblasts.
Where it falls shortSponsored by the product manufacturer; does not state a specific percentage wrinkle-depth reduction, sample size, or duration in its own abstract.
Aging skin shows a functional shift toward anaerobic (non-mitochondrial) energy metabolism; coenzyme Q10 positively influenced age-affected cellular metabolism, and topical application rapidly improved mitochondrial function in skin in vivo.
Where it falls shortSponsored by the product manufacturer. The packet's own claimed title added 'and creatine,' not present in the real title.
Coenzyme Q10 accelerated regeneration of cellular ATP levels, decreased mitochondrial dysfunction, and preserved mitochondrial membrane potential in irradiated human skin fibroblasts, primarily through its antioxidative function.
Where it falls shortIn-vitro cellular study, not a clinical trial.
In 34 healthy women aged 40-65 over 12 weeks, the supplement improved dermis density, reduced periorbital wrinkle area and total wrinkle score, and improved skin smoothness compared to placebo. Skin hydration, dermis thickness, TEWL, and viscoelasticity were not significantly changed.
Where it falls shortTests an oral supplement combining coenzyme Q10 with collagen peptides -- does not isolate coenzyme Q10's own contribution, and is not a topical application.
A source cited for a coenzyme Q10 fibroblast/mitochondrial senescence claim could not be found under its claimed title, journal, or year -- no matching publication exists.
Replaced with a genuine, closely related study by the same research group on coenzyme Q10 restoring mitochondrial function and ATP regeneration in irradiated human skin fibroblasts.
NeedsNone -- corrected directly this cycle with a genuine substitute finding.
Several specific figures in the source packet's own claim descriptions (a '27% reduction in wrinkle depth', '6-month' duration, '20 subjects' for one topical trial) are not stated in that trial's own published abstract.
Only the qualitative, confirmed finding is used; unconfirmed specific figures are not asserted.
NeedsThe trial's full published results, if a more granular figure is needed.
The packet's own claim for the water-soluble coenzyme Q10 plus collagen trial asserted a topical delivery route and a significant elasticity improvement; the real trial is an ORAL supplement, and its own abstract states elasticity/viscoelasticity changes were NOT statistically significant.
Delivery route corrected to oral; the elasticity outcome is not asserted.
NeedsNone -- corrected directly against the real abstract this cycle.
No resolved CIR/CosIng regulatory document id was found or confirmed this cycle for coenzyme Q10's cosmetic-ingredient status, despite the packet's own confident regulatory claims.
Both regulatory rows render with an explicit 'unsourced' disclosure rather than a resolved citation.
NeedsThe specific CIR Expert Panel report and EU CosIng database entry ids for ubiquinone.